US Map / New Hampshire
State NH

Clinical Trials in New Hampshire

Recruiting clinical trials with at least one study location in New Hampshire. Data updated daily from ClinicalTrials.gov.

Total Trials
38
Recruiting Now
38
← Back to US Map
Top Conditions in New Hampshire
Breast Cancer (3)Multiple Myeloma (2)Advanced Cancer (2)Mitral Valve Regurgitation (1)Epithelial Ovarian Cancer (1)Fallopian Tube Cancer (1)Primary Peritoneal Cancer (1)Neoadjuvant (1)Insomnia (1)Crohn Disease (1)Pancreas Adenocarcinoma (1)Amyotrophic Lateral Sclerosis (1)

Frequently Asked Questions — Clinical Trials in New Hampshire

How many clinical trials are currently recruiting in New Hampshire?
ClinicalMetric currently tracks 38 actively recruiting clinical trials with at least one location in New Hampshire. The total number of registered studies—including active but not currently enrolling trials—is 38. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in New Hampshire?
New Hampshire hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Multiple Myeloma, Advanced Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout New Hampshire serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in New Hampshire?
To join a clinical trial in New Hampshire, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in New Hampshire maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in New Hampshire

NCT06980948 Phase 1, Phase 2
Recruiting
Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Ne...
Condition
Chronic Neuropathic Pain
Enrollment
27 pts
Location
United States
Sponsor
Sangamo Therapeutics
View Trial →
NCT06930846 N/A
Recruiting
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in...
Condition
Brain Cancer
Enrollment
125 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce
View Trial →
NCT06205485 Phase 3
Recruiting
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rect...
Condition
Rectal Cancer
Enrollment
250 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT04302025 Phase 2
Recruiting
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable...
Condition
Non-small Cell Lung Cancer
Enrollment
99 pts
Location
United States
Sponsor
Genentech, Inc.
View Trial →
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
View Trial →
NCT06377852 Phase 3
Recruiting
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Condition
Metastatic Breast Cancer
Enrollment
500 pts
Location
United States
Sponsor
American Society of Clinical O
View Trial →
NCT02989948 N/A
Recruiting
Physician-Modified Fenestrated and Branched Aortic Endografting for TAAA
Condition
Aortic Aneurysm, Thoracoabdominal
Enrollment
80 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT03606967 Phase 2
Recruiting
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
70 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06408298 EARLY_Phase 1
Recruiting
HCQ in Resectable Localized Prostate Cancer
Condition
Resectable Localized Prostate Cancer
Enrollment
20 pts
Location
United States
Sponsor
Lionel.D.Lewis, MD
View Trial →
NCT06400563 N/A
Recruiting
MRg-NIRS Imaging System Breast Cancer Trial
Condition
Breast Cancer
Enrollment
20 pts
Location
United States
Sponsor
Keith D. Paulsen
View Trial →
NCT05641688 Phase 3
Recruiting
[18F]PI-2620 Phase 3 Histopathological Study
Condition
Alzheimer Disease
Enrollment
200 pts
Location
United States
Sponsor
Life Molecular Imaging Ltd
View Trial →
NCT06988618 N/A
Recruiting
Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Seve...
Condition
Prurigo Nodularis
Enrollment
600 pts
Location
United States, Germany
Sponsor
Galderma R&D
View Trial →
NCT05896189 N/A
Recruiting
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Surv...
Condition
Breast Cancer
Enrollment
386 pts
Location
United States, Puerto Rico
Sponsor
NRG Oncology
View Trial →
Page 2 of 2 — 38 trials total
← Prev
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology